STK11 and lung carcinoma: In addition, we previously generated an LKB1-null gene signature from 53 lung cancer cell lines to screen the Broad Institute Connectivity Map (CMAP) drug response database and the top 17 compounds that positively correlated with the LKB1-null gene signature were all compounds directly associated with CRTC activation (Cao et al., 2015).